| Literature DB >> 21612628 |
Chrysanthi Ainali1, Michelle Simon, Shiri Freilich, Octavio Espinosa, Lee Hazelwood, Sophia Tsoka, Christos A Ouzounis, John M Hancock.
Abstract
BACKGROUND: Cellular ATP levels are generated by glucose-stimulated mitochondrial metabolism and determine metabolic responses, such as glucose-stimulated insulin secretion (GSIS) from the β-cells of pancreatic islets. We describe an analysis of the evolutionary processes affecting the core enzymes involved in glucose-stimulated insulin secretion in mammals. The proteins involved in this system belong to ancient enzymatic pathways: glycolysis, the TCA cycle and oxidative phosphorylation.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21612628 PMCID: PMC3112093 DOI: 10.1186/1471-2148-11-142
Source DB: PubMed Journal: BMC Evol Biol ISSN: 1471-2148 Impact factor: 3.260
Figure 1Phylogenetic classification of GSIS genes. The proportions of genes in individual sub-pathways of the GSIS model are compared with the proportions seen for all human proteins. Blue = Universal; Red = Eukaryotic; Green = Metazoan; Purple = Vertebrate.
Proteins considered in this analysis
| Protein (Abbreviation) | PID (Hs)1 | Path-way2 | Class3 | H-M4 |
|---|---|---|---|---|
| Glucokinase (GK) | P35557 | G | U | 98.3 |
| 6-phosphofructokinase (F6P) | P17858 | G | U | 97.0 |
| fructose-bisphosphate aldolase (A) (FBa) | P04075 | G | U | 98.9 |
| fructose-bisphosphate aldolase (B) (FBb) | P05062 | G | U | 99.7 |
| fructose-bisphosphate aldolase (C) (FBc) | P09972 | G | U | 98.6 |
| glyceraldehyde 3-phosphate dehydrogenase (GAPD) | P04406 | G | U | 97.0 |
| bisphosphoglycerate phosphatase (1) (PGP1) | P18669 | G | U | 99.6 |
| bisphosphoglycerate phosphatase (2) (PGP2) | P15259 | G | U | 95.2 |
| Pyruvate kinase (PK) | P30613 | G | U | 95.5 |
| Lactate dehydrogenase A (LDHa) | P00338 | G | U | 97.6 |
| Lactate dehydrogenase B (LDHb) | P07195 | G | U | 99.1 |
| Pyruvate Dehydrogenase Complex A (PDCa) | P08559 | T | U | 99.5 |
| Pyruvate Dehydrogenase Complex B (PDCb) | P11177 | T | U | 97.5 |
| Pyruvate Dehydrogenase Complex C (PDCc) | P29803 | T | U | 87.2 |
| Citrate Synthase (CS) | O75390 | T, P | U | 97.4 |
| Aconitase (ACO) | Q99798 | T, P | U | 98.8 |
| Isocitrate Dehydrogenase (NAD+) (A) (IDHa) | P50213 | T, P | U | 98.6 |
| Isocitrate Dehydrogenase (NAD+) (G) (IDHg) | P51553 | T, P | U | 97.2 |
| Oxoglutarate Dehydrogenase Complex (OGDC) | Q02218 | T | U | 94.1 |
| Succinyl-CoA synthetase A (SCSa) | P53597 | T | U | 97.0 |
| Succinyl-CoA synthetase B (SCSb) | Q96I99 | T | U | 96.1 |
| Succinate Dehydrogenase A (SDHa) | P31040 | T | U | 94.0 |
| Succinate Dehydrogenase B (SDHb) | P21912 | T | U | 97.0 |
| Fumarase (FM) | P07954 | T, N | U | 95.3 |
| Malate Dehydrogenase (mitochondrion & cytosol) (MDH) | P40926 | T, N | U | 97.6 |
| Alanine Transaminase (AlaTA) | P24298 | N | U | 92.5 |
| Aspartate Transaminase (AspTA) | P00505 | N | U | 98.4 |
| Nucleoside Diphosphate Kinase (NDK) | O00746 | T | U | 87.8 |
| NADH: Ubiquinone oxidoreductase 1 (MT-ND1) | O15239 | R | E | 92.9 |
| NADH: Ubiquinone oxidoreductase 2 (MT-ND2) | O43678 | R | E | 93.9 |
| NADH: Ubiquinone oxidoreductase 3 (MT-ND3) | O95167 | R | E | 88.1 |
| NADH: Ubiquinone oxidoreductase 4 (MT-ND4) | O00483 | R | E | 92.7 |
| NADH: Ubiquinone oxidoreductase 5 (MT-ND5) | Q16718 | R | U | 91.3 |
| NADH: Ubiquinone oxidoreductase 6 (MT-ND6) | P56556 | R | U | 90.8 |
| NADH: Ubiquinone oxidoreductase 7 (MT-ND7) | O95182 | R | E | 95.5 |
| NADH: Ubiquinone oxidoreductase 8 (MT-ND8) | P51970 | R | U | 94.7 |
| NADH: Ubiquinone oxidoreductase 9 (MT-ND9) | Q16795 | R | U | 87.3 |
| Ubiquinol: Cytochrome c Oxidoreductase H (UQCRH) | P08574 | R | U | 92.3 |
| Ubiquinol: Cytochrome c Oxidoreductase I (UQCRI) | P47985 | R | U | 94.5 |
| Ubiquinol: Cytochrome c Oxidoreductase Q (UQCRQ) | O14949 | R | E | 85.2 |
| Ubiquinol: Cytochrome c Oxidoreductase R1 (UQCRR1) | O14957 | R | M | 92.7 |
| Ubiquinol: Cytochrome c Oxidoreductase C2 (UQCRC2) | P22695 | R | U | 93.2 |
| Cytochrome c Oxidase 6B1 (Cox6B1) | P14854 | R | E | 96.5 |
| Cytochrome c Oxidase 2* (Cox2) | P00403 | R | U | 86.8 |
| Cytochrome c Oxidase 8a (Cox8a) | P10176 | R | V | 85.5 |
| Cytochrome c Oxidase 5A (Cox5a) | P20674 | R | U | 88.0 |
| Cytochrome c Oxidase 4A (Cox4a) | P13073 | R | E | 89.9 |
| Cytochrome c Oxidase 6C (Cox6c) | P09669 | R | M | 86.7 |
| Cytochrome c Oxidase 7B (Cox7b) | P24311 | R | V | 88.8 |
| Cytochrome c Oxidase 1* (Cox1) | P00395 | R | U | 95.5 |
| Cytochrome c Oxidase 7R (Cox7r) | O14548 | R | E | 93.0 |
| Cytochrome c Oxidase 7C (Cox7c) | P15954 | R | E | 88.9 |
| Oxoglutarate Carrier (OGC) | Q02978 | N, P | E | 97.8 |
| Citrate Carrier (CIC) | P53007 | M | E | 96.5 |
| Nicotinamide nucleotide transhydrogenase (NNT) | Q13423 | S | U | 96.2 |
| Glutathione reductase (GSSGR) | P00390 | S | U | 89.3 |
| Glutathione peroxidase (GSSGP) | P07203 | S | U | 90.6 |
| Glycerol-3-phosphate dehydrogenase (FAD dependent) (GUT2P) | P43304 | N | U | 97.0 |
| Glycerol-3-phosphate dehydrogenase (NAD+) (G3PD) | P21695 | N | U | 96.8 |
| Malate Dehydrogenase (oxaloacetate-decarboxylating) (NADP+) X (MEx) | P48163 | P | U | 94.9 |
| Malate Dehydrogenase (oxaloacetate-decarboxylating)(NADP+) N (Men) | Q16798 | P | U | 96.4 |
| ATP/ADP Carrier 2 (AAC) | P05141 | M | U | 99.3 |
| cytosolic Isocitrate Dehydrogenase (NADP+) P (IDHcp) | P48735 | P | U | 82.0 |
| cytosolic Isocitrate Dehydrogenase (NADP+) C (IDHcc) | O75874 | P | U | 97.8 |
| Pyruvate Carboxylase (PC) | P11498 | T, P | U | 98.6 |
| ETF:Q oxidoreductase (ETF-QO) | Q16134 | N | U | 95.8 |
| Manganese-dependent superoxide dismutase 2 C (SOD2c) | P00441 | S | U | 88.9 |
| Manganese-dependent superoxide dismutase 2 M (SOD2 m) | P04179 | S | U | 91.9 |
| Manganese-dependent superoxide dismutase 2 E (SOD2e) | P08294 | S | U | 75.2 |
1 Uniprot Accession ID for the human protein
2 Pathway designation: G = glycolysis, T = TCA cycle, R = respiratory chain, N = NADH shuttle, P = pyruvate cycle, M = metabolite transport, S = glutathione pathway
3 Phylogenetic class
4 Human-mouse sequence similarity (%)
Figure 2Schematic representation of protein conservation in the GSIS biochemical network. Proteins are represented as circles with shading representing their level of sequence similarity between human and mouse (see Table 1). Darkly shaded proteins are most similar and lightly shaded proteins least similar. Five shades of grey are used to represent the five quintiles of the sequence similarity distribution. Proteins are separated between cytoplasm, mitochondrial membrane and mitochondrial matrix, grouped together into sub-pathways and co-localised to give an approximate representation of their functional relationships.
Figure 3Effect of sub-pathway membership on sequence divergence of GSIS proteins. Tukey's boxplot of the results of ANOVA analysis on the effect of sub-pathway membership on sequence divergence of GSIS proteins. G = glycolysis, M = metabolite transport, R = respiratory chain, S = glutathione pathway, TPN = TCA cycle+pyruvate cycle+NADH shuttle.
Figure 4Similarity of gene duplication histories in the GSIS system. The cluster diagram is constructed from Euclidian distances between vectors of gene duplication history as described in the Materials and Methods. Gene names are coloured according to their phylogenetic classification (red = Metazoan, orange = Universal, brown = Eukaryotic, green = Vertebrate). Coloured dots represent pathway membership as shown in the key. Red stars indicate genes inferred to have undergone at least one episode of positive selection, according to the Selectome database (see Table 2 for more detail).
Figure 5Matrix of inferred gene duplications in the 69 GSIS genes. Events are taken from the Ensembl gene tree displays and binned according to the taxonomic and date information given there. Bins with one or more inferred duplication are shaded, and numbers of inferred duplications at a given taxonomic level are given. These values were included in the calculation of the cluster diagram in Figure 4.
Positive selection within GSIS
| Protein | Sub-Pathway | Inferred node (approximate date) |
|---|---|---|
| MT-ND4 | R | Percomorpha (190 MYA) |
| MT-ND6 | R | Percomorpha |
| Catarrhini (31MYA) | ||
| MT-ND8 | R | Eutheria (102 MYA) |
| Tetrapoda (359 MYA) | ||
| UQCRC2 | R | Theria (166 MYA) |
| Tetrapoda | ||
| Clupeocephala (320 MYA) | ||
| Cox8A | R | Eutheria |
| Cox4A | R | Theria |
| Murinae (37 MYA) | ||
| Clupeocephala* | ||
| Euteleostomi (420 MYA)† | ||
| Cox7R | R | Catarrhini† |
| CIC | M | Eutheria |
| ETF-QO | N | Percomorpha |
* Two episodes inferred; † Coincides with a duplication
GSIS genes with disease associations
| Gene | OMIM Code | Disease |
|---|---|---|
| GCK | 125851 | MODY, type II, |
| 125853 | Insulin resistance, susceptibility to, | |
| 602485 | Hyperinsulinemic hypoglycemia, familial, 3 | |
| 606176 | Diabetes, permanent neonatal | |
| FBa | 229600 | Fructose intolerance |
| FBc | 611881 | Glycogen storage disease XII |
| PGP2 | 261670 | Glycogen storage disease X |
| PK | 102900 | Adenosine triphosphate, elevated, of erythrocytes |
| 266200 | Pyruvate kinase deficiency | |
| PDCa | 308930 | Leigh syndrome, X-linked |
| 312170 | Pyruvate dehydrogenase deficiency | |
| PDCb | 312170 | Pyruvate dehydrogenase deficiency |
| OGDC | 203740 | Alpha-ketoglutarate dehydrogenase deficiency |
| SCSa | 245400 | Lactic acidosis, fatal infantile |
| SDHa | 115310 | Paraganglioma, familial chromaffin, 4 |
| 171300 | Pheochromocytoma, modifier of | |
| 606864 | Paraganglioma and gastric stromal sarcoma | |
| 612359 | Cowden-like syndrome | |
| SDHb | 252011 | Mitochondrial respiratory chain complex II deficiency |
| 256000 | Leigh syndrome, due to Cox deficiency | |
| FM | 150800 | Multiple cutaneous and uterine leiomyomata |
| 605839 | Leiomyomatosis and renal cell cancer | |
| 606812 | Fumarase deficiency | |
| MT-ND1 | 252010 | Mitochondrial complex I deficiency |
| MT-ND2 | 256000 | Leigh syndrome, due to Cox deficiency |
| UQCRQ | 124000 | Mitochondrial complex III deficiency |
| Cox6B1 | 220110 | Mitochondrial complex IV deficiency |
| Cox2 | 220110 | Mitochondrial complex IV deficiency |
| Cox1 | 220110 | Mitochondrial complex IV deficiency |
| GUT2P | 125853 | Insulin resistance, susceptibility to |
| IDHcc | 137800 | Glioblastoma, susceptibility to |
| PC | 266150 | Pyruvate carboxylase deficiency |
| ETF-QO | 231680 | Glutaricaciduria, type IIC |
| SOD2c | 105400 | Amyotrophic lateral sclerosis, susceptibility to |
| SOD2 m | 612634 | Microvascular complications of diabetes, susceptibility to |